Search

everythinglearnresearchcommunity

for

Search:↓

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

B cells can both help and hinder the body's defense against melanoma.

Tumor cells in calcifying epithelioma of Malherbe resemble hair follicle cells.

The hairless protein is important for skin, hair, and may influence cancer development.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

A genetic mutation in the hHa1 gene creates a smaller, but still functional, hair protein without causing hair problems.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

Researchers found a new gene, hacl-1, that is active in mouse hair follicles during hair growth and may be important for hair biology.

Early diagnosis and treatment of hereditary hemochromatosis can prevent serious complications.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

The condition is linked to chromosome 12, but no mutations were found in the known genes.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Severe male pattern hair loss is linked to lower hair density in the back of the head.

CD44 variant changes start alopecia areata, but don't maintain it.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

hHb1, hHb3, and hHb6 mRNAs start expressing at the same time in hair follicles.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

The humanized AA mouse model is better for testing new alopecia areata treatments.

The document reports the first case of a rare skin condition in Colombia, the 19th case worldwide.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.